Sophysa Brain Trauma College Inaugural Meeting & Launch Meeting of ICT Multi-Center Clinical Trial (II)
Sophysa Brain Trauma College Inaugural Meeting & Launch Meeting of ICT Multi-Center Clinical Trial (II) was successfully held in Shaghai on Dec 14 which was organized by iMedcare and Shanghai Brain Trauma Research Institution.
Opening with the speech and lecture from Prof. JIANG Ji-yao, we firstly have the ceremony of Sophysa Brain Trauma College Inaugural Meeting. With great honor, we have awarded 25 neurosurgeons from different hospitals to be our key lecturer for our College and take a group picture. We aim to promote the standardized treatment of craniocerebral trauma in regional and primary hospitals, and the popularization of cranial pressure and cranial temperature monitoring.
Prof. JIANG Ji-yao
Meanwhile, we have invited Prof. John T. Povlishock, Director, Commonwealth Center for the Study of Brain Injury from Virginia Commonwealth University School of Medicine and Prof. Nino Stocchett, Department of physiopathology and transplantation, Milan University to each have a wonderful lecture. They fully discuss with all the participants on the importance and clinical value of ICP/ICT monitoring in the treatment of severe brain injury.
Prof. John T. Povlishock
Prof. Nino Stocchett
Finally, we have a launch meeting of ICT Multi-Center Clinical Trial (II) which was initiated by Shanghai Renji Hospital. It has attracted directors and Project leaders from 28 different hospitals all over China to be the member of this multi-center clinical trial. They had a hot discussion and agreed to launch the clinical trail as soon as possible. Good preparation is important to ensure effective patients’ data. It will help neurosurgeons to provide scientific evidence for ICT monitoring in clinicals. Our staff from iMedcare will closely cooperate with all project hospitals to ensure the project going well.
During the congress, we also demonstrate Pressio 2 ICP/ICT monitor to all the participants. Intuitively brings the most intuitive operation experience and product introduction to the neurosurgeons who has interest to participate in the clinical research.
EN 
CN
EN
